Amphastar Pharmaceuticals Inc (AMPH)
R&D Expense Growth
-17.10%
Quarterly · Period ending:
AMPH R&D Expense Growth
Latest reported-17.10%period ending
Latest reported-17.10%period ending
AMPH Quarterly R&D Growth (QoQ) (0.00% → -17.10%)
Latest values, visible window
High-resolution chart · PNG
AMPH r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -17.1036% | |
| 14.6822% | |
| 4.2945% | |
| 11.3247% | |
| -0.0796% | |
| 10.7706% | |
| -13.9251% | |
| 19.4029% | |
| 24.0216% | |
| -30.2953% | |
| 22.5336% | |
| -1.0628% | |
| -14.9987% | |
| 14.9629% | |
| -6.9029% | |
| -18.7911% | |
| 40.5289% | |
| -6.1495% | |
| 60.6655% | |
| -40.6302% | |
| 22.7362% | |
| -18.5739% | |
| 2.7715% | |
| 9.2575% | |
| 5.5283% | |
| -22.0984% | |
| 5.5788% | |
| 16.3166% | |
| 9.5091% | |
| -12.7106% | |
| 47.5661% | |
| -26.6874% | |
| 8.4712% | |
| 25.1646% | |
| 13.4761% | |
| -6.448% | |
| -4.6044% | |
| -8.3652% | |
| 26.2676% | |
| -7.2233% | |
| 24.9404% | |
| -3.0737% | |
| -22.1553% | |
| 3.6453% | |
| 63.3069% | |
| -14.0202% | |
| -11.0192% | |
| 43.2266% | |
| -3.4627% | |
| -14.7467% | |
| -19.4448% | |
| 16.0442% | |
| -12.5% | |
| 1.8997% | |
| 0% |